Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
It may take more years to find out if drugs discovered with DNA encoded chemical libraries (DELs) succeed at the clinical trial stage, but companies within this space are upbeat and are ...
This is a fragile moment. It’s May 1. Some of us have been in social isolation for two solid months. Everyone’s at some point on the continuum of stir crazy. More than 30 million people are ...
Although Big Pharma is investing millions of R&D dollars to find a vaccine or therapy for Covid-19 the industry is being viewed with suspicion and scorn.
There are significant global efforts underway to diagnose, treat and prevent infections from the virus. Pharmaceutical companies are working globally to combat COVID-19.
FDA has just fast-tracked research on an exciting new mental health treatment, and one small company is making moves to secure its place as an early mover in this revolution
Wall Street is experiencing some major déjà vu. The tensions between the U.S. and China flared after President Trump threatened to impose new import tariffs. The difference this time? These ...
Gilead Sciences’s remdesivir would be the first treatment to pass such a test against the virus, which has killed more than 218,000 people since it emerged late last year in China.